FEBRIS BIORISK CONSULT
ActiveSummary
FEBRIS BIORISK CONSULT has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €512,715 and a net result of €97,386. Equity has been growing by about 29% per year since 2018. Its solvency ranks better than 95% of 11,772 sector peers (NACE 71, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 29-02-2016 Normal situation
- Activity
- Engineering and related technical consultancy, excluding land surveyors NACE 71121and 3 others
- Establishment unit
- 2.250.712.675 9880 Aalter, since 29-02-2016
- Financial year end
- 31 December
- Peppol
- Reachable since 13-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €128,264
- ▼ 11.6%
- Turnover
- ≈ €260,000
- estimated
- Profit
- €97,386
- ▼ 5.3%
- Equity
- €512,715
- ▲ 23.4%
- Total assets
- €545,200
- ▲ 4.1%
Score breakdownlowers riskLiquidity: current ratio 18.22, cash €472,664Equity €512,715 (94.0% of total assets)Sector: Architectural and engineering activities; technical testing and analysis (NACE 71)Size: total assets €545,200Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 71, micro). It does better than 87% of them on solvency, 97% on liquidity, 66% on profitability and 70% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 36 days before the deadline. In the sector (NACE 71), the median for financial year 2024 was 8 days before the deadline, and 34% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: More equity than 95% of companies in architecture and engineeringsector median €63,897 · 11,777 companies €512,715 View
- Positive: 8 profitable years in a rowprofit 2025: €97,386 8 years View
- Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View
Recent changes
- · Gazette deed Change of role: DE KESEL Antoine, from manager to directorAppointment: MARES Gwenny Jeanne (director)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as FEBRIS BIORISK CONSULT: engineering and related technical consultancy, excluding land surveyors (NACE 71121). They are comparable in size and age: total assets between €472,000 and €585,000, founded between 2015 and 2016.
| Company | Total assets | Gross margin |
|---|---|---|
| FEBRIS BIORISK CONSULT Aalter | €545,200 | €128,264 |
| LDB SERVICES Lebbeke | €548,631 | €134,378 |
| JAA! Assenede | €585,183 | €142,306 |
| THINKING FORWARD Merchtem | €482,555 | €131,706 |
| Bureau Aerts – Ingénieur Conseil Namur | €472,193 | €127,455 |
| ROHESE Antwerpen | €528,542 | €109,554 |
| COLINEAIR Liège | €521,681 | €107,023 |
Key facts about FEBRIS BIORISK CONSULT
- What is the company number of FEBRIS BIORISK CONSULT?
- The company number of FEBRIS BIORISK CONSULT is 0649.484.581. The VAT number is the same number with BE in front: BE 0649.484.581.
- Where is FEBRIS BIORISK CONSULT based?
- The registered office is at Imkerstraat 8, 9880 Aalter.Company details
- What does FEBRIS BIORISK CONSULT do?
- According to the KBO register, the main activity is engineering and related technical consultancy, excluding land surveyors (NACE 71121).
- What is the legal form of FEBRIS BIORISK CONSULT?
- The legal form of FEBRIS BIORISK CONSULT is Private limited company (BV).
- When was FEBRIS BIORISK CONSULT founded?
- FEBRIS BIORISK CONSULT was founded on 29-02-2016.
- Is FEBRIS BIORISK CONSULT still active?
- Yes, FEBRIS BIORISK CONSULT is an active enterprise in the KBO register.
- What is the turnover of FEBRIS BIORISK CONSULT?
- The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €128,264 and 36 comparable companies (NACE 711). It probably lies between €200,000 and €330,000.Financials
- Is FEBRIS BIORISK CONSULT profitable?
- In financial year 2025, FEBRIS BIORISK CONSULT made a profit of €97,386.
- Where can I find the annual accounts of FEBRIS BIORISK CONSULT?
- FEBRIS BIORISK CONSULT filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FEBRIS BIORISK CONSULT due?
- FEBRIS BIORISK CONSULT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.